André Fedier

2.2k citations

52 papers · 1.5k indexed · h-index 24

Impact in

Reproductive Medicine top 5%
- Endometriosis Research and Treatment
- Ovarian cancer diagnosis and treatment
Cancer Research top 10%

Papers in

Reproductive Medicine 6
- Endometriosis Research and Treatment 6
Pathology and Forensic Medicine 10
- Genetic factors in colorectal cancer 10

Co-authors: Daniel Fink Viola Heinzelmann‐Schwarz Francis Jacob Patrick Imesch U. Haller V. Schwarz Neville F. Hacker Konstantin J. Dedes
Journals: International Journal of Oncology (7 papers)British Journal of Cancer (5 papers)PLoS ONE (3 papers)Fertility and Sterility (3 papers)Anti-Cancer Drugs (2 papers)
Partner nations: Switzerland Australia United States

In The Last Decade

André Fedier

51 papers receiving 1.4k citations

Peers

Countries citing papers authored by André Fedier

Since Specialization

Citations

This map shows the geographic impact of André Fedier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by André Fedier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites André Fedier more than expected).

Fields of papers citing papers by André Fedier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by André Fedier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by André Fedier. The network helps show where André Fedier may publish in the future.

Co-authorship network

The 25 scholars most cited alongside André Fedier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with André Fedier Line = papers co-authored together André Fedier links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Protocol for quantifying drug sensitivity in 3D patient-derived ovarian cancer models STAR Protocols ·R.P. Donnelly, Robert Broker, 顾洪建, Mónica Núñez López, André Fedier, Viola Heinzelmann‐Schwarz, Ricardo Coelho, Francis Jacob	2024	1
2	Overlapping gene dependencies for PARP inhibitors and carboplatin response identified by functional CRISPR-Cas9 screening in ovarian cancer Cell Death and Disease ·Ricardo Coelho, E. Rosa Silva, LI Chang-zhi, Robert Broker, André Fedier, Mónica Núñez López, Florian Freuler, Francis Jacob, Viola Heinzelmann‐Schwarz	2022	13
3	MyCTC chip: microfluidic-based drug screen with patient-derived tumour cells from liquid biopsies Microsystems & Nanoengineering ·Fabienne D. Schwab, Manuel C. Scheidmann, Willem Matthias d’Ablaing, André Kling, Lucas Armbrecht, Julie Brent, Ilona Krol, Karin Strittmatter, Bich Doan Nguyen-Sträuli, Francis Jacob, André Fedier, Viola Heinzelmann‐Schwarz, Andreas Wicki, Petra S. Dittrich, Nicola Aceto	2022	17
4	Transition of Mesenchymal and Epithelial Cancer Cells Depends on α1-4 Galactosyltransferase-Mediated Glycosphingolipids Cancer Research ·Francis Jacob, Jo-Han Hung, Martina Konantz, Ching-Yeu Liang, Reto S. Kohler, Arun Everest‐Dass, Yen‐Lin Huang, 顾洪建, André Fedier, Andreas Schötzau, Mónica Núñez López, Nicolle H. Packer, Claudia Lengerke, Viola Heinzelmann‐Schwarz	2018	36
5	Glucosylceramide synthase inhibitors differentially affect expression of glycosphingolipids Glycobiology ·Jo-Han Hung, André Fedier, Reto S. Kohler, Francis Jacob	2015	22
6	The glycosphingolipid P1 is an ovarian cancer-associated carbohydrate antigen involved in migration British Journal of Cancer ·Francis Jacob, Merrina Anugraham, Louis Cadiou, Brian Wan-Chi Tse, Cody Lorkin, Nader S. Metwalli, Nicolai V. Bovin, André Fedier, Neville F. Hacker, Margaret E. Huflejt, Nicolle H. Packer, Viola Heinzelmann‐Schwarz	2014	4
7	Expression of GBGT1 is epigenetically regulated by DNA methylation in ovarian cancer cells BMC Molecular Biology ·Francis Jacob, Megan P. Hitchins, André Fedier, Kevin Brennan, Sheri Nixdorf, Neville F. Hacker, Robyn L. Ward, Viola Heinzelmann‐Schwarz	2014	12
8	Histone deacetylase inhibitors down-regulate G-protein-coupled estrogen receptor and the GPER-antagonist G-15 inhibits proliferation in endometriotic cells Fertility and Sterility ·Patrick Imesch, Eleftherios Pierre Samartzis, Konstantin J. Dedes, Daniel Fink, André Fedier	2013	24
9	Conjugates of cytochrome c and antennapedia peptide activate apoptosis and inhibit proliferation of HeLa cancer cells Experimental and Therapeutic Medicine ·Patrick Imesch, David Scheiner, Emese Szabó, Daniel Fink, André Fedier	2013	6
10	Expression of the G protein-coupled estrogen receptor (GPER) in endometriosis: a tissue microarray study Reproductive Biology and Endocrinology ·Nicolas Samartzis, Eleftherios Pierre Samartzis, Aurelia Noske, André Fedier, Konstantin J. Dedes, Rosmarie Caduff, Daniel Fink, Patrick Imesch	2012	34
11	Romidepsin reduces histone deacetylase activity, induces acetylation of histones, inhibits proliferation, and activates apoptosis in immortalized epithelial endometriotic cells Fertility and Sterility ·Patrick Imesch, Daniel Fink, André Fedier	2010	31
12	Acquired vorinostat resistance shows partial cross-resistance to ‘second-generation’ HDAC inhibitors and correlates with loss of histone acetylation and apoptosis but not with altered HDAC and HAT activities Anti-Cancer Drugs ·Konstantin J. Dedes, Ioannis Dedes, Patrick Imesch, André O. von Bueren, Daniel Fink, André Fedier	2009	40
13	Hypericin and 5-aminolevulinic acid-induced protoporphyrin IX induce enhanced phototoxicity in human endometrial cancer cells with non-coherent white light Photodiagnosis and Photodynamic Therapy ·Xiaoye Schneider‐Yin, M. Linacre, A Cavalleri, Małgorzata Roos, André Fedier, Elisabeth I. Minder, Heinrich Walt	2009	28
14	Cost-effectiveness of trastuzumab in the adjuvant treatment of early breast cancer: a model-based analysis of the HERA and FinHer trial Annals of Oncology ·田村美子, Thomas D. Szucs, Patrick Imesch, André Fedier, K Heckenberg, Daniel Fink	2007	43
15	MLH1-deficient tumor cells are resistant to lipoplatin, but retain sensitivity to lipoxal Anti-Cancer Drugs ·André Fedier, Cédric Poyet, Daniele Perucchini, Teni Boulikas, Daniel Fink	2006	19
16	Role of p53 and ATM in photodynamic therapy‐induced apoptosis Lasers in Surgery and Medicine ·Viola Heinzelmann‐Schwarz, André Fedier, René Hornung, Heinrich Walt, U. Haller, Daniel Fink	2003	16
17	p53-deficient cells display increased sensitivity to anthracyclines after loss of the catalytic subunit of the DNA-dependent protein kinase International Journal of Oncology ·André Fedier, Ahmed W. Moawad, U. Haller, Daniel Fink	2003	16
18	Loss of atm sensitises p53-deficient cells to topoisomerase poisons and antimetabolites Annals of Oncology ·André Fedier, Dilina Kosgoda, V. Schwarz, U. Haller, Stephen B. Howell, Daniel Fink	2003	34
19	Photodynamic therapy of DNA mismatch repair-deficient and -proficient tumour cells British Journal of Cancer ·V. Schwarz, René Hornung, André Fedier, Mathias K. Fehr, H. Walt, U. Haller, Daniel Fink	2002	16
20	Redistribution of surface-bound Con A is quantitatively related to the movement of cells developing polarity Cell Motility and the Cytoskeleton ·André Fedier, P. Eggli, H. U. Keller	1999	5

About André Fedier

André Fedier is a scholar working on Reproductive Medicine, Pathology and Forensic Medicine, Oncology, Molecular Biology and Cancer Research, having authored 52 papers that have together received 1.5k indexed citations. Recurring topics across this work include Genetic factors in colorectal cancer (10 papers), Glycosylation and Glycoproteins Research (8 papers), DNA Repair Mechanisms (7 papers), Endometriosis Research and Treatment (6 papers), Histone Deacetylase Inhibitors Research (5 papers), Cancer-related Molecular Pathways (5 papers), Cellular Mechanics and Interactions (4 papers) and Cancer Genomics and Diagnostics (4 papers). The work is most often cited by research in Reproductive Medicine (210 citations), Cancer Research (241 citations), Oncology (399 citations), Molecular Biology (932 citations) and Obstetrics and Gynecology (99 citations). André Fedier has collaborated with scholars based in Switzerland, Australia and United States. Frequent co-authors include Daniel Fink, Viola Heinzelmann‐Schwarz, Francis Jacob, Patrick Imesch, U. Haller, V. Schwarz, Neville F. Hacker, Konstantin J. Dedes, Sheri Nixdorf and Eleftherios Pierre Samartzis. Their work appears in journals such as International Journal of Oncology, British Journal of Cancer, PLoS ONE, Fertility and Sterility and Anti-Cancer Drugs.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact